Diversity, Equity, and Inclusion Forum
Friday, May 3, 2024 1:00 PM to 4:05 PM · 3 hr. 5 min. (America/Chicago) Diversity, Equity, and Inclusion
Friday, May 3, 2024 1:00 PM to 4:05 PM · 3 hr. 5 min. (America/Chicago) Diversity, Equity, and Inclusion
AB-1002 is an investigational one-time gene therapy that promotes increased production of protein inhibitor 1.
Researchers compared reports of second primary malignant neoplasms in patients who received CAR T-cell therapies to reports in patients treated with other therapies. Researchers found…
AB-1002 is an investigational one-time gene therapy that promotes increased production of protein inhibitor 1.
“Until now, no single center has had enough samples of the quality needed for comprehensive multi-omics profiling, as we’ve carried out in this study,” says…
Non-White or Hispanic residents less likely than non-Hispanic White residents to report meaningful mentorship
Despite varied preferences for surgical vs medical treatments, most participants expressed an interest in seeking treatment for PFDs.
Maximum linear stone measurements continue to be the standard of care for stone burden characterization according to the AUA and European Association of Urology’s guidelines.…
Risk for AVF failure significantly higher for patients with higher baseline LGI, independent of age, sex, CV risk factors
“But more excitingly, as early as 9 months, even though they were small numbers, the comparison between BCG and Anktiva vs BCG alone showed a…
AI algorithms accurately predict selection of antibiotics for UTI up to three days before culture results are available. #AUA2024